Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_assertion type Assertion NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_head.
- NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_assertion description "[Thus, a mutation frequency of 40% and a cluster of three mutation types (p.G12D, pG12V, and p.G13D) in primaries and metastases can be defined as benchmarks for routine KRAS analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_provenance.
- NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_assertion evidence source_evidence_literature NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_provenance.
- NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_assertion SIO_000772 19679400 NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_provenance.
- NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_assertion wasDerivedFrom befree-2016 NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_provenance.
- NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_assertion wasGeneratedBy ECO_0000203 NP757464.RAuE_OhTG8F8Bn5HzQ2VSwz5DcAXE_Cfi50nrUYPXfVmQ130_provenance.